Close this search box.

a e r o c e p

Sampling The Lungs


No Sample


Global Burden
of Lung Infections

489 Million Cases Annually

Major Burden on Health Care System

2.49 Million Deaths Annually

Most Deadly of All Communicable Diseases

97.2 Million DALYs Annually

Prime Cause of Disability-Adjusted Life Years

Unambiguous Diagnosis is Hampered
by Conventional Sampling Methods

Better sample, Better treatment

Limitation of Conventional Sampling

Current samples are contaminated by upper respiratory tract

Poor sample, Poor diagnosis

Contamination leads to inaccurate diagnoses

Accurate Diagnosis, Right Treatment

Poor diagnosis results in under- or over-treatment

Diagnosing lung
infections is a
sampling challenge

Xheal Sampling Technology
Enables Directed Therapy

Better sample, Better treatment

a e r o c e p®

Sampling Site of Infection

Capturing pathogen-loaded aerosols originating from mucosal surfaces in the lungs

Enabling Molecular Diagnostics

Our sample carries no contamination making it ideally compatible with fast molecular diagnostics

Allowing Directed Therapy

By enabling fast molecular diagnostics, our sample allows for diagnosis within the golden hour.

Xheal Diagnostics 2024 © All Rights Reserved.